Ambu acquires patented single-use airway tubes with integrated camera

New acquisition strengthens Ambu’s visualisation portfolio.

Ambu has signed a conditional agreement to acquire Israeli-based ETView Medical Ltd. ETView owns and manufactures single-use airway tubes with a camera integrated into the tube. ETView has full patent coverage and the acquisition price is USD 16.0m on a debt and cash free basis.

ETView was founded in 2004 and has been listed on the stock exchange in Tel Aviv since 2010. ETView is based in Misgav in Israel, employs 16 people and posted a revenue of USD 2.1m in 2015.

Ambu President & CEO, Lars Marcher says: “ETView has done a fantastic job in developing a unique product line that improves patient care and helps doctors and nurses reduce complexity and save time during surgery through continuous monitoring of the patients’ airway. Today’s signing marks a strategic acquisition for Ambu that will increase our relevance to hospitals.”

Accelerate conversion to single-use
Hospitals in US, Europe and Asia are currently converting from re-usable bronchoscopes to the single-use Ambu® aScope™. The products of ETView address the same call points as the Ambu aScope and will enable Ambu to accelerate conversion of the hospital market from re-usable to single-use within the area of pulmonary endoscopy.

“The airway tubes from ETView are “plug and play” products for Ambu because they supplement the aScope, add procedure benefits and touch the same call-points in the hospitals that our sales force addresses today,” says Lars Marcher.

Completion is subject to final shareholder approval in Israel and is expected to take place during Q4 of Ambu’s current financial year. The acquisition price will be financed out of Ambu’s existing credit lines, and it is planned to have ETView de-listed from the Tel Aviv stock exchange subsequent to completion.

The transaction will have minimal impact on Ambu’s current financial guidance, and financing of the acquisition price can be contain